DX5+CD4+ T cells modulate CD4+ T-cell response via inhibition of IL-12 production by DCs

European Journal of Immunology

Volumn 43, Issue 2, 2013, Pages 439-446

  El Bannoudi, Hanane ^a   Han, Wanda G H ^a   Stoop, Jeroen N ^a   Louis Plence, Pascale ^b   Huizinga, Tom W J ^a   Toes, René ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b INSERM   (France)

Author keywords

DCs; IL 10; IL 12; Immune regulation; T cells

Indexed keywords

ALPHA2 INTEGRIN; CD4 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 12P40; INTERLEUKIN 12P70; INTERLEUKIN 4; LIPOPOLYSACCHARIDE; PROGRAMMED DEATH 1 LIGAND 1; PROGRAMMED DEATH 1 LIGAND 2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CD4+ T LYMPHOCYTE; CELL ACTIVATION; CELL CONTACT; CELL MATURATION; COCULTURE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DENDRITIC CELL; DX5+ CD4+ T LYMPHOCYTE; IMMUNOMODULATION; LYMPHOCYTE SUBPOPULATION; MOUSE; NONHUMAN; OUTCOME ASSESSMENT; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; TH1 CELL;

ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; CELL COMMUNICATION; DENDRITIC CELLS; INTERFERON-GAMMA; INTERLEUKIN-10; INTERLEUKIN-12; LIPOPOLYSACCHARIDES; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED C57BL; TH1 CELLS;

EID: 84873713409     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.201242796     Document Type: Article

References (45)

1. Sakaguchi, S., Yamaguchi, T., Nomura, T. and Ono, M., Regulatory T cells and immune tolerance. Cell 2008. 133: 775-787.
2. Wing, K. and Sakaguchi, S., Regulatory T cells exert checks and balances on self tolerance and autoimmunity. Nat. Immunol. 2010. 11: 7-13.
3. + regulatory T cells control autoimmunity? Curr. Opin. Immunol. 2005. 17: 638-642.
4. Chatila, T. A., Regulatory T cells: key players in tolerance and autoimmunity. Endocrinol. Metab. Clin. North Am. 2009. 38: 265-272, vii.
5. von Herrath, M. G. and Harrison, L. C., Antigen-induced regulatory T cells in autoimmunity. Nat. Rev. Immunol. 2003. 3: 223-232.
6. + T regulatory cell-mediated suppression. Immunity 2009. 30: 636-645.
7. +. J. Immunol. 2004. 172: 5213-5221.
8. Sojka, D. K. and Fowell, D. J., Regulatory T cells inhibit acute IFN-γ synthesis without blocking T-helper cell type 1 (Th1) differentiation via a compartmentalized requirement for IL-10. Proc. Natl. Acad. Sci. USA 2011. 108: 18336-18341.
9. + regulatory T cells suppress differentiation and functions of Th1 and Th2 cells, Leishmania major infection, and colitis in mice. J. Immunol. 2003. 170: 394-399.
10. + immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production. J. Exp. Med. 1998. 188: 287-296.
11. + T cell responses. J. Exp. Med. 2003. 198: 889-901.
12. + regulatory T cells by TGF-β induction of transcription factor Foxp3. J. Exp. Med. 2003. 198: 1875-1886.
13. + T cells protect against experimentally induced asthma and alter pulmonary dendritic cell phenotype and function. J. Exp. Med. 2005. 202: 1549-1561.
14. Kryczek, I., Wei, S., Zou, L., Zhu, G., Mottram, P., Xu, H., Chen, L. et al., Cutting edge: induction of B7-H4 on APCs through IL-10: novel suppressive mode for regulatory T cells. J. Immunol. 2006. 177: 40-44.
15. +CD25 high regulatory T cells modulate myeloid but not plasmacytoid dendritic cells activation. J. Immunol. 2006. 176: 5293-5298.
16. + regulatory T cells down-regulate co-stimulatory molecules on antigen-presenting cells. Eur. J. Immunol. 2000. 30: 1538-1543.
17. + T cells restrain the maturation and antigen-presenting function of dendritic cells. J. Immunol. 2004. 172: 4676-4680.
18. +T cells. Biochem. Biophys. Res. Commun. 2005. 330: 226-232.
19. Morlacchi, S., Dal, S. V., Soldani, C., Glaichenhaus, N., Viola, A. and Sarukhan, A., Regulatory T cells target chemokine secretion by dendritic cells independently of their capacity to regulate T cell proliferation. J. Immunol. 2011. 186: 6807-6814.
20. + regulatory T cells modulate human dendritic cell chemokines via multiple mechanisms: comment on the article by Kolar et al. Arthritis Rheum. 2009. 60: 2848-2849.
21. + regulatory T cells. J. Immunol. 2006. 177: 3806-3813.
22. + regulatory T cells suppresses ongoing arthritis. J. Autoimmun. 2010. 34: 390-399.
23. + T cells in autoimmune diabetes. Nat. Immunol. 2001. 2: 1117-1125.
24. Han, W. G., van der Voort, E. I., el Bannoudi, H., Louis-Plence, P., Huizinga, T. W. and Toes, R. E., DX5(+)CD4(+) T cells modulate cytokine production by CD4(+) T cells towards IL-10 via the production of IL-4. Eur. J. Immunol. 2010. 40: 2731-2740.
25. Han, W. G., Schuurhuis, D. H., Fu, N., Camps, M., van Duivenvoorde, L. M., Louis-Plence, P., Franken, K. L. et al., DC-induced CD8(+) T-cell response is inhibited by MHC class II-dependent DX5(+)CD4(+) Treg. Eur. J. Immunol. 2009. 39: 1765-1773.
26. Murphy, K. M. and Reiner, S. L., The lineage decisions of helper T cells. Nat. Rev. Immunol. 2002. 2: 933-944.
27. Pulendran, B., Banchereau, J., Maraskovsky, E. and Maliszewski, C., Modulating the immune response with dendritic cells and their growth factors. Trends Immunol. 2001. 22: 41-47.
28. Reis e Sousa, C. R., Dendritic cells as sensors of infection. Immunity 2001. 14: 495-498.
29. Carreno, B. M. and Collins, M., The B7 family of ligands and its receptors: new pathways for costimulation and inhibition of immune responses. Annu. Rev. Immunol. 2002. 20: 29-53.
30. Salomon, B. and Bluestone, J. A., Complexities of CD28/B7: CTLA-4 costimulatory pathways in autoimmunity and transplantation. Annu. Rev. Immunol. 2001. 19: 225-252.
31. Freeman, G. J., Long, A. J., Iwai, Y., Bourque, K., Chernova, T., Nishimura, H., Fitz, L. J. et al., Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation. J. Exp. Med. 2000. 192: 1027-1034.
32. Sandner, S. E., Clarkson, M. R., Salama, A. D., Sanchez-Fueyo, A., Domenig, C., Habicht, A., Najafian, N. et al., Role of the programmed death-1 pathway in regulation of alloimmune responses in vivo. J. Immunol. 2005. 174: 3408-3415.
33. Parry, R. V., Chemnitz, J. M., Frauwirth, K. A., Lanfranco, A. R., Braunstein, I., Kobayashi, S. V., Linsley, P. S. et al., CTLA-4 and PD-1 receptors inhibit T-cell activation by distinct mechanisms. Mol. Cell Biol. 2005. 25: 9543-9553.
34. Okazaki, T. and Wang, J., PD-1/PD-L pathway and autoimmunity. Autoimmunity 2005. 38: 353-357.
35. Fife, B. T., Pauken, K. E., Eagar, T. N., Obu, T., Wu, J., Tang, Q., Azuma, M. et al., Interactions between PD-1 and PD-L1 promote tolerance by blocking the TCR-induced stop signal. Nat. Immunol. 2009. 10: 1185-1192.
36. Fife, B. T. and Pauken, K. E., The role of the PD-1 pathway in autoimmunity and peripheral tolerance. Ann. N. Y. Acad. Sci. 2011. 1217: 45-59.
37. Keir, M. E., Liang, S. C., Guleria, I., Latchman, Y. E., Qipo, A., Albacker, L. A., Koulmanda, M. et al., Tissue expression of PD-L1 mediates peripheral T cell tolerance. J. Exp. Med. 2006. 203: 883-895.
38. Barber, D. L., Wherry, E. J., Masopust, D., Zhu, B., Allison, J. P., Sharpe, A. H., Freeman, G. J. et al., Restoring function in exhausted CD8 T cells during chronic viral infection. Nature 2006. 439: 682-687.
39. Iwai, Y., Ishida, M., Tanaka, Y., Okazaki, T., Honjo, T. and Minato, N., Involvement of PD-L1 on tumor cells in the escape from host immune system and tumor immunotherapy by PD-L1 blockade. Proc. Natl. Acad. Sci. USA 2002. 99: 12293-12297.
40. + T cell dysfunction in melanoma patients. J. Exp. Med. 2010. 207: 2175-2186.
41. Sakuishi, K., Apetoh, L., Sullivan, J. M., Blazar, B. R., Kuchroo, V. K. and Anderson, A. C., Targeting Tim-3 and PD-1 pathways to reverse T cell exhaustion and restore anti-tumor immunity. J. Exp. Med. 2010. 207: 2187-2194.
42. Wang, J., Yoshida, T., Nakaki, F., Hiai, H., Okazaki, T. and Honjo, T., Establishment of NOD-Pdcd1-/- mice as an efficient animal model of type I diabetes. Proc. Natl. Acad. Sci. USA 2005. 102: 11823-11828.
43. Ansari, M. J., Salama, A. D., Chitnis, T., Smith, R. N., Yagita, H., Akiba, H., Yamazaki, T. et al., The programmed death-1 (PD-1) pathway regulates autoimmune diabetes in nonobese diabetic (NOD) mice. J. Exp. Med. 2003. 198: 63-69.
44. Fife, B. T., Guleria, I., Gubbels, B. M., Eagar, T. N., Tang, Q., Bour-Jordan, H., Yagita, H. et al., Insulin-induced remission in new-onset NOD mice is maintained by the PD-1-PD-L1 pathway. J. Exp. Med. 2006. 203: 2737-2747.
45. + T cells to regulatory T-cell induction in non-responder mouse strains. Mol. Immunol. 2010. 48: 137-146.